Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus InfectionKimberly Workowski, Scott D. Holmberg, Ravi Jhaveri et al.|Clinical Infectious Diseases|2018Cited by 726
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patientsNorma Rallón, Vincent Soriano, Susanna Naggie et al.|AIDS|2010Cited by 202
Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral TherapyPablo Barreiro, Vincent Soriano, Juan A. Pineda et al.|The Journal of Infectious Diseases|2011Cited by 58
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIVJ. Medraño, Vincent Soriano, Karin Neukam et al.|Clinical Infectious Diseases|2010Cited by 57
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirinNorma Rallón, José M. Benito, Vincent Soriano et al.|AIDS|2011Cited by 45